After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
MYGN belongs to the Healthcare sector of the NASDAQ while operating in the Diagnostics & Research industry. The current market capitalization of Myriad Genetics, Inc is $1.18B. A total of 0.79 million shares were traded on the day, compared to an average of 1.01M shares.
In the most recent transaction, DIAZ PAUL J sold 15,000 shares of MYGN for 22.93 per share on Oct 11 ’24. After the transaction, the President and CEO now owns 962,378 company shares. In a previous transaction on Oct 11 ’24, DIAZ PAUL J bought 15,000 shares at 22.93 per share.
Among the insiders who bought shares, Ancona Margaret acquired of 11,538 shares on Aug 21 ’24 at a per-share price of $27.82. In another insider transaction, DIAZ PAUL J sold 15,000 shares at $26.72 per share on Sep 11 ’24. Company shares held by the President and CEO now total 977,378.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MYGN has a high of $29.30 and a low of $12.04.
As of this writing, MYGN has an earnings estimate of $0.03 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.03.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MYGN’s latest balance sheet shows that the firm has $338.80M in Cash & Short Term Investments as of fiscal 2021. There were $92.30M in debt and $204.30M in liabilities at the time. Its Book Value Per Share was $8.04, while its Total Shareholder’s Equity was $967.80M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MYGN is Buy with a score of 3.47.
